Navigation Links
Genetic Mutation Implicated in Charcot-Marie-Tooth Disease

Around 1 in 2500 people suffer from hereditary Charcot-Marie-Tooth (CMT) disease. The role of genetics in this disease has remained unclear. However researchers from the// Flanders Interuniversity Institute for Biotechnology (VIB) connected to the University of Antwerp have now reported that mutations in mitofusin 2 are the major cause of the disease. These important findings could also be the basis of a new genetic test.

Weakening the muscles

Charcot-Marie-Tooth (CMT) disease is the most common hereditary disorder of the peripheral nervous system, leading to a weakening of the muscles in the lower legs, feet and hands as the nerves that run from the spinal cord to the muscles die off. The syndrome is extremely variable: some patients hardly notice it, while others become confined to a wheelchair. Today, only palliative treatment is available − there are as yet no effective therapies for preventing, retarding, or stopping the course of the disease.

Knowledge of genes makes fast diagnosis possible CMT embraces a heterogeneous group of disorders, all of which are caused by mutations in certain genes. Identifying these genes is fundamental to improving diagnosis. This is important for assessing what the further course of the disease might be for a given patient. But it is also important for providing genetic advice and prenatal and pre-implantation diagnosis for couples who desire to have children but whose families have a history of the disease. Research by Vincent Timmerman's group underpinned the currently existing genetic test for CMT1A. However, for a long time scientists did not know which gene causes CMT2. In 2004, the VIB researchers in Antwerp, in collaboration with German and American research groups, showed that mitofusin 2 (MFN2) was altered in a large number of CMT2 patients.

Major cause

The current research of Kristien Verhoeven and Kristl Claeys, under the direction of Vincent Tim merman and Peter De Jonghe, reveals how important MFN2 is in the origin of CMT2. They studied 323 CMT patients, 249 of whom suffer from CMT2. From the study of these patients (and 170 healthy individuals), it is clear that mutations in MFN2 are the major cause of CMT2. On the basis of these results, genetic tests for CMT2 are now possible.

The cell's energy suppliers

In addition, this research throws light on the mechanisms behind the origin of CMT2. MFN2 is a protein with an important function in the mitochondria, the cell's energy suppliers. So, it's clear that the role of mitochondria in CMT2 needs to be studied further. This could be a key to better understanding this complex disorder. And a better understanding could be a first step toward treatment. But, for the time being, treatment is still a long way off.

Contact: Joke Comijn
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
Source: Eurekalert
'"/>




Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology: